The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ABBVIE INC | COM | 00287Y109 | 91,428 | 1,200,000 | SH | SOLE | 1,200,000 | 0 | 0 | ||
| ALEXION PHARMACEUTICALS INC | COM | 015351109 | 148,154 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 87,241 | 6,050,000 | SH | SOLE | 6,050,000 | 0 | 0 | ||
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 27,130 | 4,390,000 | SH | SOLE | 4,390,000 | 0 | 0 | ||
| ASCENDIS PHARMA A S | SPONSORED ADR | 04351P101 | 60,439 | 536,710 | SH | SOLE | 536,710 | 0 | 0 | ||
| ATARA BIOTHERAPEUTICS INC | COM | 046513107 | 12,584 | 1,478,753 | SH | SOLE | 1,478,753 | 0 | 0 | ||
| AVROBIO INC | COM | 05455M100 | 21,006 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | ||
| BIOGEN INC | COM | 09062X103 | 63,276 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| BROOKDALE SR LIVING INC | COM | 112463104 | 53,040 | 17,000,000 | SH | SOLE | 17,000,000 | 0 | 0 | ||
| CHANGE HEALTHCARE INC | COM | 15912K100 | 129,870 | 13,000,000 | SH | SOLE | 13,000,000 | 0 | 0 | ||
| COLLEGIUM PHARMACEUTICAL INC | COM | 19459J104 | 32,660 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| GLAXOSMITHKLINE PLC | SPONSORED ADR | 37733W105 | 113,670 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| GLYCOMIMETICS INC | COM | 38000Q102 | 7,980 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| HCA HEALTHCARE INC | COM | 40412C101 | 76,373 | 850,000 | SH | SOLE | 850,000 | 0 | 0 | ||
| INCYTE CORP | COM | 45337C102 | 26,396 | 360,457 | SH | SOLE | 360,457 | 0 | 0 | ||
| MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 54,400 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| MYLAN N V | SHS EURO | N59465109 | 116,223 | 7,795,000 | SH | SOLE | 7,795,000 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 33,629 | 2,350,000 | SH | SOLE | 2,350,000 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | COM | 640268108 | 53,550 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| NUVASIVE INC | COM | 670704105 | 1,704 | 33,630 | SH | SOLE | 33,630 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 7,650 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
| PERRIGO CO PLC | SHS | G97822103 | 96,180 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
| PUMA BIOTECHNOLOGY INC | COM | 74587V107 | 16,458 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 70,920 | 725,000 | SH | SOLE | 725,000 | 0 | 0 | ||
| SUTRO BIOPHARMA INC | COM | 869367102 | 6,120 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| TENET HEALTHCARE CORP | COM NEW | 88033G407 | 50,400 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| TRANSLATE BIO INC | COM | 89374L104 | 17,597 | 1,765,000 | SH | SOLE | 1,765,000 | 0 | 0 | ||
| UNIVERSAL HLTH SVCS INC | CL B | 913903100 | 111,465 | 1,125,000 | SH | SOLE | 1,125,000 | 0 | 0 | ||
| VENTAS INC | COM | 92276F100 | 87,100 | 3,250,000 | SH | SOLE | 3,250,000 | 0 | 0 | ||